The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Care: Access & Affordability

Rheumatology Care: Access & Affordability

June 13, 2021 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF
  • Attend conferences and sessions that discuss legislative issues;
  • Use the ACR’s Legislative Action Center and the Voter Voice app to contact lawmakers. The ACR has prepopulated letters on such issues as step therapy and student loan repayment. You can add a line to share a personal note about a patient or explain how something related to these issues has affected your practice, Dr. Solow said;
  • Stay up to date on key policy issues with resources like ACR@Work, an e-newsletter deployed twice a month;
  • Contribute to RheumPAC, the ACR’s nonpartisan political action committee. “This is a way members can use funds to be at meetings with legislators who are working on issues impacting rheumatology,” Dr. Solow said;
  • Take part in the ACR’s visits to Capitol Hill that are scheduled twice a year. You don’t need “expert knowledge” of policy issues to attend, Dr. Solow said. You only need passion to share your experience as a healthcare provider with lawmakers.

“The ACR will help walk you through where the issues stand and what we believe. I never felt unprepared,” Dr. Snow said.

You Might Also Like
  • ACR Puts Forward Principles on Patient Access to Care
  • Protect Your Patients’ Access to Care & Treatment
  • Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing
Explore This Issue
June 2021
Also By This Author
  • Business of Rheum Session to Outline What to Expect with MIPS Value Pathways

Dr. Solow updated attendees on some of the bills that affect rheumatology, including two bills (H.R. 2163 and S. 464) related to step therapy that have good traction in both the House and Senate, with bipartisan support. “We’re hoping to get those across the finish line or attached to other large pieces of legislation,” she said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

There also is a bill for prior authorization that has not been introduced yet in the 117th Congress.


Vanessa Caceres is a medical writer in Bradenton, Fla.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Legislation & Advocacy, Patient Perspective Tagged With: Access to care, costsIssue: June 2021

You Might Also Like:
  • ACR Puts Forward Principles on Patient Access to Care
  • Protect Your Patients’ Access to Care & Treatment
  • Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing
  • ACR & NPF Highlight Medicare Access Challenges in Capitol Hill Briefing

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)